11 Recruiting Bladder Cancer Phase 3 Clinical Trials
Active phase 3 studies for bladder cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Bladder Cancer studiesPhase 3 Studies for Bladder Cancer
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
π Arizona Urology Specialists β Tucson, Arizona
View Study & Checklist βQUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
π Alaska Clinical Research Center β Anchorage, Alaska
View Study & Checklist βA Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer
π Loma Linda University Medical Center β Loma Linda, California
View Study & Checklist βPerioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
π Mayo Clinic in Arizona - Phoenix ( Site 0043) β Phoenix, Arizona
View Study & Checklist βA Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-GuΓ©rin (BCG) in Participants With BCG-naΓ―ve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
π Mayo Clinic β Scottsdale, Arizona
View Study & Checklist βOutcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
π Sibley Memorial Hospital β Washington D.C., District of Columbia
View Study & Checklist βA Study of Surgical Techniques During Cystectomy
π Memorial Sloan Kettering at Basking Ridge (Consent Only) β Basking Ridge, New Jersey
View Study & Checklist βNeoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)
π The Ottawa Hospital β Ottawa, Ontario
View Study & Checklist βEvaluating Safety and Efficacy of Verity-BCG in BCG-naΓ―ve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)
π Site 05 β Vancouver, British Columbia
View Study & Checklist βA Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
π Munson Medical Center ( Site 0812) β Traverse City, Michigan
View Study & Checklist βAlvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
π Brigham and Women's Hospital β Boston, Massachusetts
View Study & Checklist β